Sign in to view content

VERONA: End-of-Study Results From a Phase 2 Trial of EYP-1901 (Vorolanib Intravitreal Insert) vs Aflibercept for Diabetic Macular Edema

Yasha S Modi, MD

Video
Published 2025

Related

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2017
Durability of Combination Therapy of Sozinibercept, an Anti-VEGF-C/D 'Trap' With Ranibizumab in nAMD or Aflibercept in DME
Nathan C. Steinle, MD
Annual Meeting Talks
2024
Clinical Experience With the SCS Microinjector for Suprachoroidal Injections by Ophthalmologists
Milan Shah, MD
Annual Meeting Talks
2019

Category: Diabetic Macular Edema

See more